Skip to content

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05904782
Enrollment
150
Registered
2023-06-15
Start date
2025-08-29
Completion date
2027-11-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

To learn more about the experience and wellbeing of people who provide care for cancer patients.

Detailed description

OBJECTIVES Primary Objectives: The primary objective of this proposal is to identify relevant themes and content essential to adapt PAT to a caregiving in advanced cancer context (PAT-C) and develop a Brief (5-session) version of PAT-C. Findings from this study are essential to inform future RCTs to test the feasibility, efficacy, dose and explore potential mediators of treatment outcomes of this intervention. Secondary Objectives: The secondary objective is to characterize psychosocial distress and psychosocial health of caregivers in the supportive care clinic. This data will be essential to inform appropriateness of the supportive care clinic as a potential site for future RCTs (i.e., determine if there are enough caregivers in this clinic who might benefit from this specific supportive care strategy).

Interventions

None listed

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
American Cancer Society, Inc.
CollaboratorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Males and female adults ≥18 years * Able to read and speak English * Caregiver of a patient diagnosed with stage IV solid malignancy, with whom they have been residing for \>6 months * Access to necessary resources for participating in a technology-based intervention (i.e., telephone, internet access)

Exclusion criteria

* Current participation in consistent (self-defined) psychotherapy * Caregivers who are considered part of a vulnerable population (i.e. cognitively impaired (self-reported or patient-reported), pregnant, military personnel) will not be eligible.

Design outcomes

Primary

MeasureTime frame
Quality of Life questionnaire (Qol)through completion of study; approximately 1 month

Countries

United States

Contacts

CONTACTJuliet Kroll
jlkroll@mdanderson.org(346) 723-5858
PRINCIPAL_INVESTIGATORJuliet Kroll

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026